| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cytogenetic model predicts relapse risk and survival in patients with acute myeloid leukemia undergoing hematopoietic stem cell transplantation in morphologic complete remission
|
Rashidi, Armin
|
|
2015
|
39 |
1 |
p. 77-81
5 p.
|
artikel
|
| 2 |
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014
|
Visconte, Valeria
|
|
2015
|
39 |
1 |
p. 110-113
4 p.
|
artikel
|
| 3 |
Chemotherapy dose in obese AML patients: To cap or not to cap?
|
Percival, Mary-Elizabeth M.
|
|
2015
|
39 |
1 |
p. 30-32
3 p.
|
artikel
|
| 4 |
Chronic mast cell leukemia: A novel leukemia-variant with distinct morphological and clinical features
|
Valent, Peter
|
|
2015
|
39 |
1 |
p. 1-5
5 p.
|
artikel
|
| 5 |
c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
|
Xia, Bing
|
|
2015
|
39 |
1 |
p. 92-99
8 p.
|
artikel
|
| 6 |
Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors
|
Lipton, J.H.
|
|
2015
|
39 |
1 |
p. 58-64
7 p.
|
artikel
|
| 7 |
CRM1 as a new therapeutic target for non-Hodgkin lymphoma
|
Han, Xiaohong
|
|
2015
|
39 |
1 |
p. 38-46
9 p.
|
artikel
|
| 8 |
Editorial board and publication information
|
|
|
2015
|
39 |
1 |
p. IFC-
1 p.
|
artikel
|
| 9 |
Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias
|
Goodings, Charnise
|
|
2015
|
39 |
1 |
p. 100-109
10 p.
|
artikel
|
| 10 |
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms
|
Jones, Amy V.
|
|
2015
|
39 |
1 |
p. 82-87
6 p.
|
artikel
|
| 11 |
Isolated +15 in bone marrow: Disease-associated or a benign finding?
|
Goswami, Rashmi Shivani
|
|
2015
|
39 |
1 |
p. 72-76
5 p.
|
artikel
|
| 12 |
Malignant hematopoietic cell lines: In vitro models for the study of primary mediastinal B-cell lymphomas
|
Drexler, Hans G.
|
|
2015
|
39 |
1 |
p. 18-29
12 p.
|
artikel
|
| 13 |
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
|
Falantes, Jose
|
|
2015
|
39 |
1 |
p. 52-57
6 p.
|
artikel
|
| 14 |
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: Kinetics of its appearance and potential predictive role in infectious complications
|
Belotti, Angelo
|
|
2015
|
39 |
1 |
p. 88-91
4 p.
|
artikel
|
| 15 |
Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: Short report from a single centre
|
Alizadeh, H.
|
|
2015
|
39 |
1 |
p. 47-51
5 p.
|
artikel
|
| 16 |
Severe infusion-related reactions are uncommon in rituximab-treated CLL patients in clinical practice: Results from a Swedish national observational study
|
Norin, Stefan
|
|
2015
|
39 |
1 |
p. 33-37
5 p.
|
artikel
|
| 17 |
Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL+ leukemia cells
|
Nguyen, Tri
|
|
2015
|
39 |
1 |
p. 65-71
7 p.
|
artikel
|
| 18 |
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
|
Zhang, Ling
|
|
2015
|
39 |
1 |
p. 6-17
12 p.
|
artikel
|
Tijdschrift beschrijving